Trial Search Results

Neonatal Seizure Registry - Developmental Functional EValuation

The NSR-DEV study is a longitudinal cohort study of around 280 Neonatal Seizure Registry participants that aims to evaluate childhood outcomes after acute symptomatic neonatal seizures, as well as examine risk factors for developmental disabilities and whether these are modified by parent well-being.

Stanford is currently accepting patients for this trial.

Lead Sponsor:

University of California, San Francisco

Collaborator: University of Michigan

Stanford Investigator(s):


Inclusion Criteria:

   - Enrolled in NSR-II

   - Alive at the start of the NSR-DEV study period

   - Parent(s) who are English or Spanish literate (with assistance of interpreter)

Exclusion Criteria:

   - Neonates who were found to have exclusion criteria after NSR-II enrollment

   - Risk for adverse outcome independent of seizures and underlying brain injury
   (including but not limited to: inborn errors of metabolism, fetal infection, brain

   - Transient cause for seizures (e.g., mild hypoglycemia, hyponatremia, hypocalcemia with
   normal neuroimaging)

   - Neonatal-onset epilepsy syndromes

Ages Eligible for Study

2 Years - 8 Years

Genders Eligible for Study


Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Courtney J. Wusthoff, MD